FDA 483 - ABBE Laboratories, Inc. - February 27, 2025
FDA 483 for ABBE Laboratories, Inc. on February 27, 2025. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for ABBE Laboratories, Inc. on February 27, 2025. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
ABBE Laboratories, Inc.Inspection Date
February 27, 2025
Product Type
drugs
Office
New York District OfficePeople
ID: 421f7934-1785-4930-b611-ea9ee73df69d
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox